Sign in

CIK 0001818844

  • Non-accelerated filer
  • Smaller reporting company

Dogwood Therapeutics, Inc.

Sign in to watch
Ticker
DWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
854314201
Phone
+1 866-620-8655
Business address
44 MILTON AVENUE, ALPHARETTA, GA, 30009
Former names
Virios Therapeutics, Inc., Virios Therapeutics, LLC
  1. 4 Open-market buy Director bought 8,827 shares at $5.66 ($49,997)
  2. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,000 shares at $5.52 ($27,615)
  3. 4 Open-market buy Director bought 942 shares at $6.32 ($5,951)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Chief Executive Officer bought 382 shares at $6.36 ($2,429)
  14. 4/A Open-market buy Chief Executive Officer bought 15,675 shares at $6.17 ($96,757)
  15. 4 Open-market buy Chief Executive Officer bought 15,675 shares at $6.17 ($96,757)
  16. 4 Open-market buy VP of Finance bought 1,000 shares at $7.30 ($7,300)
  17. 4 Open-market buy Director bought 3,500 shares at $7.47 ($26,145)
  18. 4 Exercise or conversion Director acquired 1,602 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 6 · 117 filings